Host: Charles Turck, PharmD, BCPS, BCCCP

Guest: Mark Pennesi, MD, PhD

Approximately 165,700 people in the United States are affected by inherited retinal diseases (IRDs) and treatment options for these conditions are limited. So what role does genetic testing play in the patient journey of people living with IRDs? Join Dr. Charles Turck as he dives into this topic with Dr. Mark Pennesi, Professor of Ophthalmology and an IRD specialist affiliated with the Casey Eye Institute at the Oregon Health and Science University School of Medicine.

©Janssen Pharmaceuticals, Inc. 2023 05/23 cp-367503v1